Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.
Combining chemotherapy and hormone therapy for the treatment of luminal metastat...
Prof Hesham El-Ghazaly - Ain Shams University, Cairo, Egypt
Combining chemotherapy and hormone therapy for the treatment of luminal metastatic breast cancer ( Prof Hesham El-Ghazaly - Ain Shams University, Cairo, Egypt )
27 Jan 2020
Endocrine toxicities of immunotherapy
Dr Ricky Frazer - Velindre Cancer Centre, Cardiff, Wales
Endocrine toxicities of immunotherapy ( Dr Ricky Frazer - Velindre Cancer Centre, Cardiff, Wales )
13 Jan 2020
Endocrine dysfunction in patients receiving immunotherapy
Sherwin Criseno - University Hospitals Birmingham, Birmingham, UK
Endocrine dysfunction in patients receiving immunotherapy ( Sherwin Criseno - University Hospitals Birmingham, Birmingham, UK )
13 Jan 2020
The PEARL study: Palbociclib and endocrine therapy vs capecitabine in HR /HER2- ...
Dr Miguel Martín - Universidad Complutense de Madrid, Madrid, Spain
The PEARL study: Palbociclib and endocrine therapy vs capecitabine in HR /HER2- metastatic breast cancer ( Dr Miguel Martín - Universidad Complutense de Madrid, Madrid, Spain )
19 Dec 2019
Exploring adjuvant endocrine therapy use with letrozole in postmenopausal women ...
Dr Terry Mamounas - Orlando Health UF Health Cancer Center, Orlando, USA
Exploring adjuvant endocrine therapy use with letrozole in postmenopausal women with hormone receptor-positive breast cancer ( Dr Terry Mamounas - Orlando Health UF Health Cancer Center, Orlando, USA )
19 Dec 2019
Long-term influence of oestrogen plus progestin vs oestrogen alone on breast can...
Prof Rowan Chlebowski - City of Hope National Medical Center, Duarte, USA
Long-term influence of oestrogen plus progestin vs oestrogen alone on breast cancer incidence in post-menopausal women ( Prof Rowan Chlebowski - City of Hope National Medical Center, Duarte, USA )
19 Dec 2019
Breast cancer prevention in high-risk post-menopausal women
Prof Jack Cuzick - Queen Mary University of London, London, UK
Breast cancer prevention in high-risk post-menopausal women ( Prof Jack Cuzick - Queen Mary University of London, London, UK )
18 Dec 2019
Preventative effects of anastrozole in post-menopausal women who are at high-ris...
Prof Jack Cuzick - Queen Mary University of London, London, UK
Preventative effects of anastrozole in post-menopausal women who are at high-risk for developing breast cancer ( Prof Jack Cuzick - Queen Mary University of London, London, UK )
18 Dec 2019
Breast cancer incidence in post-menopausal women: Long-term influence of oestrog...
Prof Rowan Chlebowski - City of Hope National Medical Center, Duarte, USA
Breast cancer incidence in post-menopausal women: Long-term influence of oestrogen plus progestin versus oestrogen alone ( Prof Rowan Chlebowski - City of Hope National Medical Center, Duarte, USA )
18 Dec 2019
Addition of S-1 to post-operative endocrine therapy for patients with hormone re...
Prof Masakazu Toi - Kyoto University, Kyoto, Japan
Addition of S-1 to post-operative endocrine therapy for patients with hormone receptor-positive HER2-negative breast cancer ( Prof Masakazu Toi - Kyoto University, Kyoto, Japan )
18 Dec 2019
Laser therapy for vulvo-vaginal atrophy / genito-urinary syndrome of menopause i...
Prof Deborah Fenlon - Swansea University, Swansea, UK
Laser therapy for vulvo-vaginal atrophy / genito-urinary syndrome of menopause in breast cancer survivors ( Prof Deborah Fenlon - Swansea University, Swansea, UK )
12 Dec 2019
PROfound: PARP inhibitor olaparib compared with new hormonal agents in advanced ...
Prof Maha Hussain - Northwestern University Feinberg School of Medicine, Chicago...
PROfound: PARP inhibitor olaparib compared with new hormonal agents in advanced castration resistant prostate cancer ( Prof Maha Hussain - Northwestern University Feinberg School of Medicine, Chicago, USA )
7 Nov 2019